Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

BS B2B Bureau  |  Mumbai 

Lupin receives US FDA nod for sleep disorder drug armodafinil

The US Food and Drug Administration (FDA) has granted its final approval for Ltd’s tablet (in strengthens of 50 mg, 150 mg, 200 mg and 250 mg), which is used for treating sleep disorder. The company had filed the application for the new drug from its Goa manufacturing facility.

The company’s US subsidiary Pharmaceuticals Inc is expected to commence promotion of this approved product, a version of Inc’s tablet, in the US shortly. 

are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy or shift work disorder (SWD). tablet had US sales of $ 515.6 million, according to MAT September 2016.

RECOMMENDED FOR YOU

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million
The US Food and Drug Administration (FDA) has granted its final approval for Ltd’s tablet (in strengthens of 50 mg, 150 mg, 200 mg and 250 mg), which is used for treating sleep disorder. The company had filed the application for the new drug from its Goa manufacturing facility.

The company’s US subsidiary Pharmaceuticals Inc is expected to commence promotion of this approved product, a version of Inc’s tablet, in the US shortly. 

are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy or shift work disorder (SWD). tablet had US sales of $ 515.6 million, according to MAT September 2016.

image
Business Standard
177 22

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

The US Food and Drug Administration (FDA) has granted its final approval for Ltd’s tablet (in strengthens of 50 mg, 150 mg, 200 mg and 250 mg), which is used for treating sleep disorder. The company had filed the application for the new drug from its Goa manufacturing facility.

The company’s US subsidiary Pharmaceuticals Inc is expected to commence promotion of this approved product, a version of Inc’s tablet, in the US shortly. 

are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy or shift work disorder (SWD). tablet had US sales of $ 515.6 million, according to MAT September 2016.

image
Business Standard
177 22